279 studies found for:    "Adenocarcinoma of lung"
Show Display Options
Rank Status Study
21 Recruiting Tepotinib Phase II Study in Lung Adenocarcinoma Harbouring MET Exon 14 (METex14) Skipping Alterations
Condition: Lung Adenocarcinoma Stage IIIB/IV
Intervention: Drug: tepotinib
22 Recruiting Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung Adenocarcinomas
Condition: Stage IV Lung Adenocarcinoma
Interventions: Drug: Certolizumab;   Drug: cisplatin;   Drug: pemetrexed
23 Active, not recruiting Study of the Safety and Activity of Lenvatinib (E7080) in Subjects With KIF5B-RET-Positive Adenocarcinoma of the Lung
Condition: KIF5B-RET-Positive Adenocarcinoma of the Lung
Intervention: Drug: Lenvatinib
24 Unknown  Expression of Optic Atrophy Type 1 (OPA1) Protein in Lung Adenocarcinoma
Condition: Lung Adenocarcinoma
Intervention:
25 Recruiting Comparative Study of Chemoradiation and Sequential Chemoradiation About Lung Adenocarcinoma Patients With Postoperative in pN2
Condition: Lung Adenocarcinoma Patients With Postoperative in pN2
Intervention: Radiation: intensity-modulated radiation
26 Recruiting A Randomized Phase II Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma.
Conditions: Carcinoma, Non-Small-Cell Lung;   Lung Adenocarcinoma
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Bevacizumab;   Drug: Metformin
27 Active, not recruiting Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer
Conditions: Adenocarcinoma of the Lung;   Non-small Cell Lung Cancer
Interventions: Drug: erlotinib hydrochloride;   Drug: Hsp90 inhibitor AUY922;   Other: laboratory biomarker analysis;   Procedure: needle biopsy;   Genetic: mutation analysis;   Other: pharmacological study
28 Recruiting Methoxyamine, Pemetrexed Disodium, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIIA-IV Non-small Cell Lung Cancer
Conditions: Metastatic Malignant Neoplasm in the Brain;   Stage IIIA Large Cell Lung Carcinoma;   Stage IIIA Lung Adenocarcinoma;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Large Cell Lung Carcinoma;   Stage IIIB Lung Adenocarcinoma;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IV Large Cell Lung Carcinoma;   Stage IV Lung Adenocarcinoma;   Stage IV Non-Small Cell Lung Cancer
Interventions: Radiation: 3-Dimensional Conformal Radiation Therapy;   Drug: Cisplatin;   Radiation: Intensity-Modulated Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Drug: Methoxyamine;   Drug: Pemetrexed Disodium
29 Recruiting An Integrated Approach to Treating Recurrent Thoracic Carcinomas Resistant to Tyrosine Kinase Inhibitors
Conditions: Adenocarcinoma of Lung;   Lung Neoplasm;   Cancer of Lung;   Lung Cancer;   Pulmonary Cancer;   EGFR Genes;   ALK Genes
Intervention:
30 Active, not recruiting SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma
Conditions: Mesothelioma;   Adenocarcinoma of Lung;   Pancreatic Neoplasms
Interventions: Drug: Pentostatin;   Drug: Cyclophosphamide;   Biological: SS1(dsFv)PE38 - lot 073I0809;   Biological: SS1(dsFv)PE38 - lot FIL129J01
31 Completed Vaccine Treatment for Advanced Non-Small Cell Lung Cancer
Conditions: Non-small Cell Carcinoma;   Adenocarcinoma of Lung;   Squamous Cell Carcinoma;   Large Cell Carcinoma;   Lung Neoplasms
Intervention: Biological: Drug: Hyperacute Lung Cancer Cell Vaccine
32 Completed Treatment of Lung Adenocarcinoma With Bronchioloalveolar Feature
Conditions: Pneumonic-type Adenocarcinoma (P-ADC);   Lung Adenocarcinoma With Bronchiolo-alveolar Feature
Intervention: Drug: Gefitinib
33 Recruiting Therapeutic Strategies in Patients With Non-squamous Non-small Cell Lung Cancer With Brain Metastases
Conditions: Non-small Cell Lung Cancer Metastatic;   Non-small Cell Lung Cancer;   Adenocarcinoma of Lung Metastatic to Brain;   Cerebral Metastases
Interventions: Drug: Cisplatin;   Drug: Pemetrexed;   Drug: Bevacizumab;   Radiation: Cerebral Radiotherapy
34 Recruiting Low-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung Cancer
Conditions: Adenocarcinoma of the Lung;   Recurrent Non-small Cell Lung Cancer;   Stage IA Non-small Cell Lung Cancer;   Stage IB Non-small Cell Lung Cancer;   Stage IIA Non-small Cell Lung Cancer;   Stage IIB Non-small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer
Interventions: Drug: acetylsalicylic acid;   Other: laboratory biomarker analysis
35 Not yet recruiting A Study to Predict Gefitinib' s Efficacy for Lung Cancer by Plasma Free Nucleic Acids EGFR Gene Mutation Test
Condition: Lung Adenocarcinoma
Intervention:
36 Active, not recruiting
Has Results
Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung Cancer
Conditions: Adenosquamous Lung Carcinoma;   Bronchioloalveolar Carcinoma;   Lung Adenocarcinoma;   Malignant Pericardial Effusion;   Malignant Pleural Effusion;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IV Non-Small Cell Lung Cancer
Interventions: Drug: Carboplatin;   Drug: Erlotinib Hydrochloride;   Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel
37 Recruiting Registry Measuring the Impact of Adding RNA Expression Testing on Referral Decisions in Early Stage Lung Cancer Patients and Assessing the Disease-free Survival With Long-term Follow-up
Conditions: Lung Cancer;   NSCLC;   Lung Adenocarcinoma
Intervention:
38 Recruiting Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
Conditions: Bronchioloalveolar Carcinoma;   Large Cell Lung Carcinoma;   Lung Adenocarcinoma;   Lung Adenocarcinoma, Mixed Subtype;   Squamous Cell Lung Carcinoma;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Non-Small Cell Lung Cancer
Interventions: Radiation: 3-Dimensional Conformal Radiation Therapy;   Drug: Carboplatin;   Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel;   Other: Placebo;   Drug: Veliparib
39 Terminated
Has Results
A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC
Conditions: Non-Small-Cell Lung Adenocarcinoma;   Non-small Cell Lung Cancer Stage IIIB;   Non-small Cell Lung Cancer Stage IV;   Non-small Cell Lung Cancer Metastatic
Interventions: Drug: Docetaxel;   Drug: Ganetespib
40 Active, not recruiting Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Recurrent Large Cell Lung Carcinoma;   Recurrent Lung Adenocarcinoma;   Recurrent Squamous Cell Lung Carcinoma;   Stage IV Large Cell Lung Carcinoma;   Stage IV Lung Adenocarcinoma;   Stage IV Squamous Cell Lung Carcinoma
Interventions: Biological: Bevacizumab;   Drug: Carboplatin;   Biological: Cetuximab;   Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years